RBC cuts Biogen price target to $256
RBC Capital lowered its Biogen price target to $256.00 per share from $260.00, according to Benzinga’s ratings-action report.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
RBC cuts Biogen price target to $256
RBC Capital reduced its Biogen price target to $256 from $260, according to a Benzinga ratings action report.